Glibenclamide inhibits thromboxane A2-induced contraction in human internal mammary artery and saphenous vein.

[1]  C. Delaey,et al.  Heterogeneity of the inhibitory influence of sulfonylureas on prostanoid-induced smooth muscle contraction. , 1997, European journal of pharmacology.

[2]  M. Iskander,et al.  The thromboxane A2 and K(ATP) channel antagonist actions of a series of sulphonylurea derivatives in the pig coronary artery. , 1997, European journal of pharmacology.

[3]  C. Delaey,et al.  Prostanoid-induced contractions are blocked by sulfonylureas. , 1995, European journal of pharmacology.

[4]  G. He,et al.  Effect of Thromboxane A2 Antagonist GR32191B on Prostanoid and Nonprostanoid Receptors in the Human Internal Mammary Artery , 1995, Journal of Cardiovascular Pharmacology.

[5]  R. Armstrong,et al.  Aspects of the thromboxane receptor system. , 1995, General pharmacology.

[6]  D. Cook,et al.  Antagonism of eicosanoid-induced contraction of rat aorta by sulphonylureas. , 1994, Pharmacology.

[7]  S. Narumiya,et al.  International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes. , 1994, Pharmacological reviews.

[8]  W. Hubbard,et al.  Endothelin‐induced contraction and mediator release in human bronchus , 1993, British journal of pharmacology.

[9]  M. Sokolovsky.  Endothelins and sarafotoxins: physiological regulation, receptor subtypes and transmembrane signaling. , 1992, Pharmacology & therapeutics.

[10]  J. Nielsen-Kudsk,et al.  Antidiabetic sulfonylureas relax isolated rabbit coronary arteries. , 1991, European journal of pharmacology.

[11]  C. Labat,et al.  Inhibitory effects of BAY u3405 on prostanoid‐induced contractions in human isolated bronchial and pulmonary arterial muscle preparations , 1991, British journal of pharmacology.

[12]  N. Stockbridge,et al.  Glibenclamide relaxes vascular smooth muscle constriction produced by prostaglandin F2 alpha. , 1991, European journal of pharmacology.

[13]  Z. Terashita,et al.  Endothelin-1 and platelet activating factor stimulate thromboxane A2 biosynthesis in rat vascular smooth muscle cells. , 1990, Biochemical pharmacology.

[14]  L. Aguilar-Bryan,et al.  Molecular mechanisms of action of glyburide on the beta cell. , 1990, The American journal of medicine.

[15]  J. Angus,et al.  Glibenclamide is a competitive antagonist of the thromboxane A2 receptor in dog coronary artery in vitro , 1990, British journal of pharmacology.

[16]  E. Reynolds,et al.  Role of thromboxane A2/prostaglandin H2 receptor in the vasoconstrictor response of rat aorta to endothelin. , 1990, The Journal of pharmacology and experimental therapeutics.

[17]  F. Rosenfeldt,et al.  Reactivity of human isolated internal mammary artery to constrictor and dilator agents. Implications for treatment of internal mammary artery spasm. , 1989, Circulation.

[18]  N. Standen,et al.  Hyperpolarizing vasodilators activate ATP-sensitive K+ channels in arterial smooth muscle. , 1989, Science.

[19]  B. P. White,et al.  GR32191, a highly potent and specific thromboxane A2 receptor blocking drug on platelets and vascular and airways smooth muscle in vitro , 1989, British journal of pharmacology.

[20]  T. Resink,et al.  Activation of phospholipase A2 by endothelin in cultured vascular smooth muscle cells. , 1989, Biochemical and biophysical research communications.

[21]  F. Rosenfeldt,et al.  Reactivity of the Canine Isolated Internal Mammary Artery, Saphenous Vein, and Coronary Artery to Constrictor and Dilator Substances: Relevance to Coronary Bypass Graft Surgery , 1988, Journal of cardiovascular pharmacology.

[22]  M. Lazdunski,et al.  The receptor for antidiabetic sulfonylureas controls the activity of the ATP-modulated K+ channel in insulin-secreting cells. , 1987, The Journal of biological chemistry.

[23]  B. Lönnqvist,et al.  Acute myeloblastic leukemia and non-hodgkin lymphoma. , 1979, The New England journal of medicine.

[24]  J. Elder,et al.  VASCULAR PROSTACYCLIN MAY BE REDUCED IN DIABETES IN MAN , 1979, The Lancet.